Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Elite", market "China A-shares", market cap "Large $10–200B": 20 match(clear filters).

# Ticker Mkt Cap Score Baillie 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760 · Shenzhen $27B
95/100 Elite
52/100 30.1%low 21.4% 10 yr+ Net cash 64% Mindray Bio-Medical: The Transition Is Real, But So Is the Price TagJul 19, 2026 · Hold FY2025
2 Foshan Haitian Flavouring and Food Co Ltd 603288 · Shanghai $31B
92/100 Elite
26.3%low 17.0% 10 yr+ Net cash 41% FY2025
3 Gongniu Group Co Ltd 603195 · Shanghai $11B
91/100 Elite
36.5%low 24.2% 10 yr+ Net cash 41% FY2025
4 Midea Group Co Ltd 000333 · Shenzhen $94B
88/100 Elite
43/100 22.1%low 17.8% 10 yr+ Net cash 26% Midea Group Initiation: Proven Appliance Compounder, Unearned Industrial Re-RatingAug 12, 2026 · Hold FY2025
5 Hangzhou Hikvision Digital Technology Co Ltd 002415 · Shenzhen $48B
88/100 Elite
23.9%low 14.8% 10 yr+ Net cash 49% FY2025
6 Inner Mongolia Yili Industrial Group Co Ltd 600887 · Shanghai $24B
88/100 Elite
21.5%low 15.9% 10 yr+ Net cash 34% FY2025
7 Zhangzhou Pientzehuang Pharmaceutical Co Ltd 600436 · Shanghai $12B
88/100 Elite
38/100 20.3%low 14.8% 10 yr+ Net cash 44% Pientzehuang: High-Priced Core Volume Fell 21% in 2025, and CNY132.59 Still Prices In 42x Trailing EarningsAug 15, 2026 · Hold FY2025
8 Gree Electric Appliances Inc of Zhuhai 000651 · Shenzhen $33B
87/100 Elite
24.9%low 19.3% 10 yr+ Net cash 29% FY2025
9 Hithink RoyalFlush Info Network 300033 · Shenzhen $25B
87/100 Elite
48/100 26.7%low 19.0% 10 yr+ Net cash 90% Hithink RoyalFlush: Advertising Supplied 78% of 2025 Incremental Revenue, and CNY230.26 Already Sits at the CNY228 Base-Case ValueAug 15, 2026 · Hold FY2025
10 Eastroc Beverage Group Co Ltd 605499 · Shanghai $14B
87/100 Elite
50/100 34.5%low 19.9% 9 yr Net cash 45% Eastroc Beverage: Energy Supplies 81% of Product Gross Profit While Growing 6.9%, and RMB122.93 Leaves No Conservative Margin of SafetyAug 15, 2026 · Hold FY2025
11 Henan Shuanghui Investment & Development Co Ltd 000895 · Shenzhen $13B
87/100 Elite
27.6%low 21.3% 10 yr+ Net cash 17% FY2025
12 Anker Innovations Technology Co Ltd 300866 · Shenzhen $10B
87/100 Elite
26.6%low 15.9% 10 yr+ Net cash 45% FY2025
13 Shanxi Xinghuacun Fen Wine Factory Co Ltd 600809 · Shanghai $22B
86/100 Elite
38/100 29.0%low 12.7% 10 yr+ Net cash 72% Shanxi Fenjiu: 22% More Volume but Only 7.5% More Revenue in 2025, Q1 2026 Out-of-Province Sales Fell 15% While Dealers Grew, and CNY123.52 Sits Above Conservative ValueAug 15, 2026 · Hold FY2025
14 Aier Eye Hospital Group 300015 · Shenzhen $12B
86/100 Elite
43/100 17.4%low 14.2% 10 yr+ Net cash 49% Aier Eye Hospital: Net Goodwill Equals 43% of Book Equity, Adjusted Profit Grew 1.36% in 2025, and CNY8.71 Leaves No Conservative Margin of SafetyAug 15, 2026 · Hold FY2025
15 Jiangsu Hengrui Medicine Co Ltd 600276 · Shanghai $50B
83/100 Elite
51/100 16.5%low 10.3% 10 yr+ Net cash 86% Hengrui Pharmaceuticals: A Fortress Innovation Platform, But RMB 50 Already Pays for the UpgradeJun 26, 2026 · Hold FY2025
16 Luzhou Lao Jiao Co Ltd 000568 · Shenzhen $19B
83/100 Elite
24.6%low 16.9% 10 yr+ Net cash 81% FY2025
17 Foxconn Industrial Internet Co Ltd 601138 · Shanghai $158B
82/100 Elite
40/100 22.0%low 15.0% 10 yr+ Net cash 8% FII Zen Horizon Research: No. 1 in AI server rack assembly, real earnings acceleration, but a thin business at a rich valuationJun 4, 2026 · Watch FY2025
18 Suzhou TFC Optical Communication Co Ltd 300394 · Shenzhen $26B
82/100 Elite
48/100 19.9%low 12.7% 10 yr+ Net cash 53% T&S Communications: A Real Upstream Bottleneck, Priced as if Scarcity Economics Were PermanentJul 28, 2026 · Avoid FY2025
19 Avic Shenyang Aircraft Co Ltd 600760 · Shanghai $17B
82/100 Elite
19.2%low 9.5% 10 yr+ Net cash 10% FY2025
20 NARI Technology Co Ltd 600406 · Shanghai $27B
81/100 Elite
51/100 15.3%low 14.2% 10 yr+ Net cash 27% NARI Technology: Grid-Control Franchise, Quality Already PricedJun 27, 2026 · Hold FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.